<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">Primary antiphospholipid syndrome</z:e> (APS) is a thrombophilic disorder which is not associated with <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> or with other diseases </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Retrospective review of patients diagnosed of primary APS in an Internal Medicine service between January 1996 and December 2000 </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: We identified 17 patients with primary APS </plain></SENT>
<SENT sid="3" pm="."><plain>The most common presenting manifestations were <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> (7 cases) and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (3 cases) </plain></SENT>
<SENT sid="4" pm="."><plain>Eleven patients (65%) had vein <z:mp ids='MP_0005048'>thrombosis</z:mp>, 4 (24%) <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and no patient had both types of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The 15 patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> received treatment with indefinite oral anticoagulation (INR between 2.5 and 3.5) </plain></SENT>
<SENT sid="6" pm="."><plain>There was no recurrence of <z:mp ids='MP_0005048'>thrombosis</z:mp> or major hemorrhagic complications after a median follow-up time of 36 months (range 10-52 months) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The most common presenting manifestation of primary APS is <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0004936'>Venous thrombosis</z:hpo> is more frequent than <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The occurrence of both types of <z:mp ids='MP_0005048'>thrombosis</z:mp> seems to be exceptional </plain></SENT>
<SENT sid="10" pm="."><plain>Long-term oral anticoagulation is an effective and safe treatment to prevent the recurrence of <z:mp ids='MP_0005048'>thrombosis</z:mp> in patients with primary APS </plain></SENT>
</text></document>